Thyroid storm is a medical emergency that can occur in patients with hyperthyroidism, such as those with Graves’ disease. It is characterized by symptoms such as high fever, rapid heartbeat, jaundice, and altered mental status. In such cases, IV beta-blockers, such as propranolol, are the first-line treatment to inhibit the peripheral adrenergic effects of excess thyroid hormone. However, propranolol should not be used in patients with asthma or reversible COPD, and caution should be exercised in patients with heart failure. Lugol’s solution can also be used to inhibit the release of stored thyroid hormone, but it is usually delayed until after antithyroid therapy has been initiated. Therapeutic plasma exchange may be considered for patients who do not respond to medical therapy. In this case, the patient’s jaundice is likely due to her hyperthyroid crisis, and there is no evidence of biliary disease or cholecystitis. Therefore, IV co-amoxiclav, which is the first-line antibiotic for community-acquired pneumonia, would be appropriate for this patient. If propranolol is contraindicated, a cardiac-specific beta-blocker or calcium-channel blocker may be used instead. However, in this patient, IV propranolol should be used as the first-line treatment.

Understanding Thyroid Storm

Thyroid storm is a rare but serious complication of thyrotoxicosis, which is characterized by an overactive thyroid gland. It is usually seen in patients who already have thyrotoxicosis and is not typically the first symptom. It is important to note that an excess of thyroxine caused by medication does not usually lead to thyroid storm.

There are several events that can trigger thyroid storm, including surgery, trauma, infection, and exposure to iodine, such as through CT contrast media. The clinical features of thyroid storm include fever, tachycardia, confusion, nausea, vomiting, hypertension, heart failure, and abnormal liver function tests.

The management of thyroid storm involves treating the underlying cause and providing symptomatic relief. This may include medications such as beta-blockers, anti-thyroid drugs, Lugol’s iodine, and dexamethasone. Paracetamol may also be used to manage fever.

In summary, thyroid storm is a serious complication of thyrotoxicosis that requires prompt medical attention. Understanding the triggers and clinical features of thyroid storm can help with early diagnosis and effective management.

The vignette describes classic symptoms of pericarditis, including a sharp central chest pain that is relieved by sitting up and leaning forward, but worsened by lying flat or taking deep breaths. The patient’s past medical history of systemic lupus also increases the likelihood of pericarditis. On auscultation, scratchy, rubbing S1 and S2 sounds can be heard. The most likely ECG finding in this case is saddle shaped ST elevation, which is a hallmark of pericarditis. Other potential causes of ST elevation include STEMI and left bundle branch block, but these can be ruled out based on the symptoms and examination findings. Narrow peaking T waves are often seen in hyperkalaemia, but this is not the most likely ECG finding in this case.

Understanding Acute Pericarditis

Acute pericarditis is a medical condition characterized by inflammation of the pericardial sac that lasts for less than 4-6 weeks. The condition can be caused by various factors such as viral infections, tuberculosis, uraemia, post-myocardial infarction, autoimmune pericarditis, radiotherapy, connective tissue disease, hypothyroidism, malignancy, and trauma. Symptoms of acute pericarditis include chest pain, non-productive cough, dyspnoea, and flu-like symptoms. Patients may also experience pericardial rub.

To diagnose acute pericarditis, doctors may perform an electrocardiogram (ECG) to check for changes in the heart’s electrical activity. Blood tests may also be conducted to check for inflammatory markers and troponin levels. Patients suspected of having acute pericarditis should undergo transthoracic echocardiography.

Treatment for acute pericarditis depends on the underlying cause. Patients with high-risk features such as fever or elevated troponin levels may need to be hospitalized. However, most patients with pericarditis secondary to viral infection can be managed as outpatients. Strenuous physical activity should be avoided until symptoms resolve and inflammatory markers normalize. A combination of nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine is typically used as first-line treatment for patients with acute idiopathic or viral pericarditis. The medication is usually tapered off over 1-2 weeks.

Overall, understanding acute pericarditis is important for prompt diagnosis and appropriate management of the condition.

Phenytoin: Mechanism of Action and Adverse Effects

Phenytoin is a medication used to manage seizures. Its mechanism of action involves binding to sodium channels, which increases their refractory period. However, the drug is associated with a large number of adverse effects, which can be categorized as acute, chronic, idiosyncratic, and teratogenic. Acute effects include dizziness, diplopia, nystagmus, slurred speech, ataxia, confusion, and seizures. Chronic effects include gingival hyperplasia, hirsutism, coarsening of facial features, drowsiness, megaloblastic anemia, peripheral neuropathy, enhanced vitamin D metabolism causing osteomalacia, lymphadenopathy, and dyskinesia. Idiosyncratic effects include fever, rashes, hepatitis, Dupuytren’s contracture, aplastic anemia, and drug-induced lupus. Teratogenic effects are associated with cleft palate and congenital heart disease. Although routine monitoring of phenytoin levels is not necessary, trough levels should be checked before dosing in cases of dose adjustment, suspected toxicity, or non-adherence to the prescribed medication.

To ensure proper identification of any pathology during the upper GI endoscopy, it is recommended that the patient discontinues the use of proton pump inhibitors, such as omeprazole, at least two weeks prior to the procedure.

Investigating Gastro-Oesophageal Reflux Disease

Gastro-oesophageal reflux disease (GORD) can be difficult to diagnose as there is often a poor correlation between symptoms and the appearance of the oesophagus during endoscopy. However, there are certain indications for upper GI endoscopy, including age over 55 years, symptoms lasting more than four weeks or persistent symptoms despite treatment, dysphagia, relapsing symptoms, and weight loss. If endoscopy is negative, further investigation may be necessary. The gold standard test for diagnosis is 24-hour oesophageal pH monitoring. It is important to consider these investigations in order to accurately diagnose and treat GORD.

Diagnostic Tests for Cellulitis: Which Ones are Necessary?

Cellulitis is a clinical diagnosis, but certain tests may be necessary in patients with a systemic response. A full blood count, urea and electrolytes, and CRP/ESR are recommended to assess the severity of the infection. A wound swab and blood cultures may also be considered. An ABPI measurement is indicated in patients with suspected lower-limb arterial disease. A chest X-ray is not necessary unless co-existing lung pathology is suspected. In stable patients with no systemic upset, no further investigations are needed. A punch biopsy is not necessary for diagnosis but may be considered in other skin conditions.

Treatment Options for Atrial Fibrillation: Warfarin, DOACs, Aspirin, Digoxin, Furosemide, and Lidocaine

Patients with atrial fibrillation and a CHA2DS2-VASC score of 4 require anticoagulation to reduce the risk of a CVA. The two main options are warfarin and DOACs, but the choice depends on other co-morbidities and patient preference. Before starting warfarin, patients should be referred to the Anticoagulation Clinic and screened for contraindications.

Aspirin has no benefit in atrial fibrillation, and digoxin should only be used for short-term rate control due to evidence of increased mortality with long-term use. Furosemide can help with symptoms and edema in heart failure but does not improve mortality. Lidocaine is only appropriate for ventricular arrhythmias in unstable patients and requires specialist support.

In summary, the treatment options for atrial fibrillation vary depending on the patient’s individual circumstances and should be carefully considered by healthcare professionals.

Perthes’ disease is commonly seen in children aged between 4 and 8 years, as is the case with this untreated patient. The other age ranges mentioned are not typical for this condition.

Understanding Perthes’ Disease

Perthes’ disease is a degenerative condition that affects the hip joints of children, typically between the ages of 4-8 years. It is caused by a lack of blood supply to the femoral head, which leads to bone infarction and avascular necrosis. This condition is more common in boys, with around 10% of cases being bilateral. The symptoms of Perthes’ disease include hip pain, stiffness, reduced range of hip movement, and a limp. Early changes can be seen on an x-ray, such as widening of the joint space, while later changes include decreased femoral head size and flattening.

To diagnose Perthes’ disease, a plain x-ray is usually sufficient. However, if symptoms persist and the x-ray is normal, a technetium bone scan or magnetic resonance imaging may be necessary. If left untreated, Perthes’ disease can lead to complications such as osteoarthritis and premature fusion of the growth plates.

The severity of Perthes’ disease is classified using the Catterall staging system, which ranges from stage 1 (clinical and histological features only) to stage 4 (loss of acetabular integrity). Treatment options include keeping the femoral head within the acetabulum using a cast or braces, observation for children under 6 years old, and surgical management for older children with severe deformities. The prognosis for Perthes’ disease is generally good, with most cases resolving with conservative management. Early diagnosis is key to improving outcomes.

If a patient has poorly controlled hypertension despite being on an ACE inhibitor, CCB, and thiazide diuretic, adding an alpha- or beta-blocker is recommended by NICE if their potassium levels are above 4.5mmol/l. It is important to assess the patient for postural hypotension and discuss adherence with them. Seeking specialist advice is also advised. Fludrocortisone is not appropriate for treating hypertension and may increase blood pressure. Spironolactone would be the next step if potassium levels were below 4.5mmol/l. Indapamide cannot be increased any further if the patient is already on the maximum dose. It is important to treat hypertension promptly, especially if it has been confirmed through ABPM on multiple occasions.

NICE Guidelines for Managing Hypertension

Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.

The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.

NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.

New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.

Differential Diagnosis: Abdominal Swelling and Tenderness in a Female Patient

Ovarian carcinoma is the most likely diagnosis for a female patient presenting with abdominal swelling and tenderness. This type of cancer is the leading cause of gynecological cancer deaths in developed countries, with a higher incidence in women over 55 years of age and those with a family history of breast or ovarian cancer. Imaging studies, such as ultrasonography, CT, and MRI, can aid in diagnosis, along with elevated levels of Ca-125. Surgery is often the initial treatment, followed by chemotherapy. However, the prognosis for advanced cases is poor.

Cervical carcinoma is unlikely in this patient, as it typically presents with abnormal vaginal bleeding, discomfort, and discharge, which are not reported.

Cirrhosis of the liver is a possibility, but the patient does not display common signs and symptoms, such as coagulopathy, hepatic encephalopathy, or variceal bleeding.

Wilson disease is a rare inherited disorder of copper metabolism that can cause hepatic dysfunction, but this patient does not display the characteristic hyperpigmentation, hepatomegaly, or diabetes mellitus.

Haemochromatosis is also unlikely, as the patient does not display the clinical features of the disease, such as hyperpigmentation, hepatomegaly, or diabetes mellitus, and there is no evidence of iron overload.

Metformin is typically the first choice for diabetes treatment due to its positive impact on weight. Sulphonylureas are usually the second option, unless they cause hypoglycaemia or are not well-tolerated. If sulphonylureas are not an option, alternatives like DPP4 inhibitors or thiazolidinediones may be considered. Insulin is the next line of treatment after metformin and sulphonylureas, but DPP4 inhibitors may be preferred if insulin is not suitable or if the patient wants to avoid injections or weight gain. However, DPP4 inhibitors should only be continued if they are effective, as they can be expensive.

When it comes to metformin and renal function, it is recommended to stop using it if creatinine levels exceed 150mmol/L or eGFR is below 30ml/min/1.73m². Caution is advised when eGFR is between 30-45ml/min/1.73m², taking into account the rate of deterioration in renal function. For example, if eGFR has remained stable at 33ml/min/1.73m² for six months, it may be reasonable to continue using metformin. However, if eGFR has decreased from 50 to 38ml/min/1.73m², it is likely that metformin should be discontinued due to the risk of lactic acidosis.

NICE updated its guidance on the management of type 2 diabetes mellitus (T2DM) in 2022, reflecting advances in drug therapy and improved evidence regarding newer therapies such as SGLT-2 inhibitors. The first-line drug of choice remains metformin, which should be titrated up slowly to minimize gastrointestinal upset. HbA1c targets should be agreed upon with patients and checked every 3-6 months until stable, with consideration for relaxing targets on a case-by-case basis. Dietary advice includes encouraging high fiber, low glycemic index sources of carbohydrates and controlling intake of foods containing saturated fats and trans fatty acids. Blood pressure targets are the same as for patients without type 2 diabetes, and antiplatelets should not be offered unless a patient has existing cardiovascular disease. Only patients with a 10-year cardiovascular risk > 10% should be offered a statin, with atorvastatin 20mg as the first-line choice.